Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022548

See Plans and Pricing

« Back to Dashboard

NDA 022548 describes ZYMAXID, which is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. Additional details are available on the ZYMAXID profile page.

The generic ingredient in ZYMAXID is gatifloxacin. There are sixteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the gatifloxacin profile page.

Summary for 022548

Tradename:	ZYMAXID
Applicant:	Allergan
Ingredient:	gatifloxacin
Patents:	0
Formulation / Manufacturing:	see details

Pharmacology for NDA: 022548

Suppliers and Packaging for NDA: 022548

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ZYMAXID	gatifloxacin	SOLUTION/DROPS;OPHTHALMIC	022548	NDA	Allergan, Inc.	0023-3615	0023-3615-01	1 BOTTLE, DROPPER in 1 CARTON (0023-3615-01) > 1 mL in 1 BOTTLE, DROPPER
ZYMAXID	gatifloxacin	SOLUTION/DROPS;OPHTHALMIC	022548	NDA	Allergan, Inc.	0023-3615	0023-3615-25	1 BOTTLE, DROPPER in 1 CARTON (0023-3615-25) > 2.5 mL in 1 BOTTLE, DROPPER

Paragraph IV (Patent) Challenges for 022548

Tradename	Dosage	Ingredient	NDA	Submissiondate
ZYMAXID	SOLUTION/DROPS;OPHTHALMIC	gatifloxacin	022548	2010-12-07

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION/DROPS;OPHTHALMIC			Strength	0.5%
Approval Date:	May 18, 2010	TE:	AT	RLD:	Yes

Expired US Patents for NDA 022548

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	ZYMAXID	gatifloxacin	SOLUTION/DROPS;OPHTHALMIC	022548-001	May 18, 2010	Start Trial	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.